Our Mission
The Portland Institute for Psychedelic Science (PIPS) is dedicated to advancing the field of psychedelic research and therapies. We seek to better understand and refine the therapeutic potential of psychedelics through rigorous scientific research, to offer transformative psychedelic-assisted therapies grounded in evidence-based practices, and to cultivate excellence among psychedelic-assisted therapy providers through our specialized training programs. Committed to healing and innovation, we strive to advance the standard for efficacy and integrity in psychedelic science and services across the region.
What We Do
What Makes PIPS Unique
- Research
- Practice
- Training
- Reflection
Our experience in conducting psychedelic research, providing psychedelic-assisted therapy, and educating other professionals under one roof provides a range of benefits. Our ability to comprehensively integrate knowledge from research evidence and applied practice creates a feedback loop between research and practice that continually enhances each facet of our work. This synergy allows for the rapid translation of research findings into practical therapeutic techniques, ensuring that our services are always at the cutting edge of the field.
Furthermore, our multifaceted approach fosters a rich learning environment for professionals, enhancing their skills and understanding of psychedelic science in a way that an institution with a narrower focus cannot. This inclusive and integrative model not only sets a high standard for treatment efficacy and professional training but also positions us as a leader in the field, contributing significantly to the advancement of psychedelic science and its acceptance in mainstream healthcare.
What We Have to Say
-
Which Psychedelics Show Up Most in Recent Research? Psilocybin, by a Wide Margin
If it feels like every new psychedelics paper is about psilocybin, you're not imagining it. Our lab analyzed 1,803 recent articles, and psilocybin appeared in more titles than the other five major substances combined.
-
Where Is Psychedelic Research Published? The Top 10 Journals, and How We Found Them
Where is psychedelic research actually published? Using an automated workflow that tracked 1,803 publications across 588 journals, our lab mapped the top 10 journals in the field, and shares the process so other research teams can build their own.
-
Oregon Ran an Unprecedented Experiment. Now There Are Numbers.
The first study tracking safety and mental health outcomes in Oregon's state-regulated psilocybin program is now published in JAMA Network Open. PIPS co-founder Jason Luoma breaks down what the numbers show, and what they don't.
-
How Should We Measure Safety and Quality in Supervised Psilocybin Services?
How do we know if supervised psilocybin services are safe, ethical, and helpful? A new study from the OPEN research network develops consensus measures for tracking quality, safety, and outcomes in community-based psilocybin services.
